Management Report
Management Report

6. Calculation of EBIT(DA) Before Special Items

Key performance indicators for the Bayer Group are EBIT before special items and EBITDA before special items. These indicators are reported in order to allow a more accurate assessment of business operations. The special items – comprising effects that are non-recurring or do not regularly recur or attain similar magnitudes – are detailed in the following table. “EBITDA,” “EBITDA before special items” and “EBIT before special items” are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. The company considers EBITDA before special items to be a more suitable indicator of operating performance since it is not affected by depreciation, amortization, write-downs/write-backs or special items. The company also believes that this indicator gives readers a clearer picture of the results of operations and ensures greater comparability of data over time. The EBITDA margin before special items, which is the ratio of EBITDA before special items to sales, serves as a relative indicator for the internal and external comparison of operational earning power.
Depreciation and amortization rose by 2.0% in the first three quarters of 2010 to €2,097 million (9M 2009: €2,056 million), comprising €1,183 million (9M 2009: €1,112 million) in amortization and write-downs of intangible assets and €914 million (9M 2009: €944 million) in depreciation and write-downs of property, plant and equipment. Depreciation and amortization included write-downs of €162 million, of which €30 million did not constitute special items.
Special Items Reconciliation[Table 13]
 EBIT*
3rd
Quarter
2009
EBIT*
3rd
Quarter
2010
EBIT*
First Nine
Months
2009
EBIT*
First Nine
Months
2010
EBITDA**
3rd
Quarter
2009
EBITDA**
3rd
Quarter
2010
EBITDA**
First Nine
Months
2009
EBITDA**
First Nine
Months
2010
 € million€ million€ million€ million€ million€ million€ million€ million
After special items6465562,6402,7581,3261,2204,6964,855
HealthCare10550602681045058136
Schering integration350(36)0340(38)0
   of which gain
   from divestitures

0

0

(114)

0

0

0

(114)

0
Write-downs0001320000
Litigations565056136565056136
Additional funding for the pension assurance association
14

0

40

0

14

0

40

0
CropScience4338612150030386104500
Restructuring480760350590
Litigations(1)38634500(1)38634500
Additional funding for the pension assurance association
(4)

0

11

0

(4)

0

11

0
MaterialScience150950110620
Restructuring170790130460
Additional funding for the pension assurance association
(2)

0

16

0

(2)

0

16

0
Reconciliation280390280390
Additional funding for the pension assurance association
28

0

39

0

28

0

39

0
Total special items191436315768173436263636
Before special items8379922,9553,5261,4991,6564,9595,491

* EBIT as per income statements

** EBITDA = EBIT plus amortization of intangible assets and depreciation of property, plant and equipment.

http://www.stockholders-newsletter-q3-2010.bayer.com/en/calculation-of-ebit-da--before-special-items.aspx

Copyright © Bayer AG

Print Page

Search

Download Center

Publications

Services

Special Interest